Comparison of methods of evaluating nephrotoxicity of cis-platinum

Clinical Pharmacology and Therapeutics
B R JonesM M Reidenberg

Abstract

The urinary excretion of leucine aminopeptidase (LAP), N-acetyl-beta-glucosaminidase (NAG), and beta 2-microglobulin was measured in 12 cancer patients receiving cis-platinum to evaluate the sensitivity of these indices for renal tubular damage. NAG and LAP excretion rose markedly in all patients, and beta 2-microglobulin rose in 11. Seven of the 9 patients who had received cis-platinum 6 wk before the study had prestudy dose elevations of one or more of these indices. We conclude that these urinary proteins are sensitive indicators of proximal renal tubular injury and may provide greater sensitivity for comparison of the nephrotoxic potential of future platinum analogs or for assessing the efficacy of regimens designed to protect the kidney from platinum nephrotoxicity than other measurements. The persistence of high excretion vales for these indices 6 wk after a dose demonstrates the persistent renal injury by cis-platinum.

Citations

Dec 13, 1985·Pharmaceutisch Weekblad. Scientific Edition·D T SleijferN H Mulder
Jan 1, 1984·Medical and Pediatric Oncology·J KurtzbergT R Kinney
Jan 1, 1994·Cancer Chemotherapy and Pharmacology·V PinzaniP Balmès
Dec 1, 1993·The Annals of Pharmacotherapy·A J Anand, B Bashey
Jan 8, 2014·Journal of Clinical Laboratory Analysis·Hongwei SongHui Cong
Dec 13, 2017·Experimental Biology and Medicine·Blessy GeorgeLauren M Aleksunes
Nov 15, 1986·Cancer·P FjeldborgP E Helkjaer
Oct 1, 1983·Australian and New Zealand Journal of Medicine·H G Healy, A R Clarkson
Dec 1, 1982·Cancer Chemotherapy and Pharmacology·S D HarrisonR C Giles
Jul 1, 1996·Renal Failure·C DonadioA Gadducci
Jan 1, 1986·Cancer Chemotherapy and Pharmacology·M P GorenM E Horowitz
Jan 1, 1982·Cancer Chemotherapy and Pharmacology·A H CalvertK R Harrap
Jun 1, 1984·Naunyn-Schmiedeberg's Archives of Pharmacology·U DienerU Klotz
Jan 1, 1990·Journal of Cancer Research and Clinical Oncology·U Metz-KurschelE Aulbert
Jan 1, 1981·Clinical and Experimental Dialysis and Apheresis·M M Reidenberg
Jan 1, 1985·Cancer Investigation·A I EinzigE Greenberg
May 1, 1982·Cancer·J D BitranC M Shapiro
Jul 1, 1986·Medical Toxicology·J L Carson, B L Strom
Oct 1, 1995·Clinical Pharmacology and Therapeutics·B Blöchl-DaumH G Eichler
Jun 12, 2012·Renal Failure·Beom Jin LimDae Eun Choi
Jul 5, 2017·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Sandra L Kane-GillErin Frazee
Mar 1, 1985·Bulletin of Environmental Contamination and Toxicology·S D HarrisonR C Giles
Jan 1, 1989·Cancer Chemotherapy and Pharmacology·G Daugaard, U Abildgaard
Apr 12, 2005·Journal of Pharmacological Sciences·Yoshinori ItohRyozo Oishi
Jan 1, 1991·Critical Reviews in Toxicology·A Bernard, R R Lauwerys
Mar 1, 1982·British Journal of Clinical Pharmacology·L F Prescott
Jan 1, 1985·European Journal of Clinical Pharmacology·A S TirelliB M Assael
Aug 20, 2011·International Journal of Clinical Oncology·Takayuki TakimotoKinya Abe
Mar 3, 1999·Journal of Chromatography. B, Biomedical Sciences and Applications·J GyslerU Jaehde
Sep 1, 1986·The Science of the Total Environment·K NogawaE Kobayashi
May 1, 1997·The Medical Clinics of North America·D Choudhury, Z Ahmed
Jan 1, 1988·The American Journal of the Medical Sciences·S UmekiR Soejima

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.